Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS ...Middle East

CARLSBAD, Calif., April 5, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the initiation of a Phase 3 clinical trial of ION363 in patients with amyotrophic lateral sclerosis (ALS) with mutations in the fused in sarcoma gene (FUS). Patients with a mutation...

Hence then, the article about ionis initiates phase 3 trial of novel antisense medicine to treat leading cause of juvenile onset als was published today ( Monday 05/04/2021 - 02:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS )

Last updated : 05 April 2021 clock 02:45 PM

Also on site :

2000s Heavy Metal Band Shares Exciting Music Festival News
Saudi to Sudan: Can Pakistan expand military footprint across Arab world?
Large house fire near Buckeye Lake kills one, critically injures second victim

Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS ...Middle East

Kremlin welcomes European U-turn on talks with Russia

DHS Takes a Fake News Bulldozer to Jessica Tarlov's Claim ICE Officers Don't Get 'Real Training'

West Midlands police boss ‘due to retire’ amid Maccabi fan ban fallout

The Opener: Tucker, Roster Moves, Fan Events

Map Shows USS Abraham Lincoln’s Path Towards Iran as Protests Continue

Nordstrom Rack Has a Warm and Stylish Hunter Beanie on Sale for Just $20 in 4 Staple Colors

Wegmans expands recalls of Locatelli Grated Pecorino Romano cheese due to contamination

Varonis Systems, Inc. (VRNS) Hit with Securities Class Action Amid Renewal and ARR Concerns That Drove Shares Down 48% - Hagens Berman

Berlinale Special Gala Title ‘Heysel 85’ Boarded by Salaud Morisset (EXCLUSIVE)

No reasonable precautions could have prevented Glencoe deaths, sheriff concludes

Early Addition: Stand down, it's not Whiskey Friday after all

How the White House and governors want to fix AI-driven power shortages and price spikes

Jimmy Kimmel trolls Trump after taking Nobel Peace Prize medal from the actual winner: ‘It’s like a pacifier’

The race to succeed Seth Moulton is crowded. Here’s who’s running.

Shoppers say they get asked if they’re wearing Baccarat Rouge while using this $39 dupe